C
CoreLife at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
CoreLife brings 3 presentations to ObesityWeek 2026 in National Harbor. Its program centres on liver disease screening in people with obesity and on everyday outcomes of GLP-1 therapy. It covers why FIB-4 is an unreliable screen for liver fibrosis in obesity and early functional and emotional results from the BEACON study.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
C CoreLife | |
Obesity care company running medical weight-management clinics in partnership with health systems such as Novant Health. | Poster Sat Nov 14 7:30pm–8:30pm FIB-4 Is an Unreliable Screening Tool for Hepatic Fibrosis in Persons With Obesity Chronic disease and obesity complications Poster Sat Nov 14 7:30pm–8:30pm Prevalence of Hepatic Fibrosis and Steatosis in Patients With Obesity Chronic disease and obesity complications Talk Sun Nov 15 8:45am–9:00am |
Find decision makers at CoreLife
Tell us what you sell and we’ll find the people at CoreLife most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction